Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

CHMP recommends lifting marketing restrictions on Serdolect

April 26, 2005

New formulations of dapsone for cerebral infarction

April 26, 2005

EMEA completes review of antidepressants in children and adolescents

April 26, 2005

Positive findings for low-dose doxepin in elderly patients with insomnia

April 26, 2005

Similar analgesic effects found for M6G and morphine sulfate after major surgery

April 26, 2005

Guilford restarts Aquavan program

April 25, 2005

Progression of pivotal study of MBP-8298 for secondary progressive MS

April 25, 2005

Trexima achieves endpoints in second phase III trial

April 25, 2005

Ondansetron reported to improve memory function in schizophrenia

April 25, 2005

SkyePharma and Mundipharma enter DepoBupivacaine agreement

April 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...